BrightSpring Health Services (BTSG) traded higher after investors continued to position around the company’s recently completed portfolio reshaping and capital-markets activity. The most recent company milestone is the March 31, 2026 completion of the sale of its ResCare Community Living business to Sevita, which narrows BrightSpring’s operating focus toward its home-based care and pharmacy platforms. (brightspringhealth.gcs-web.com)

Sentiment has also been supported by the company’s March 2026 secondary offering, where selling shareholders offered 20 million shares, alongside BrightSpring’s plan to repurchase up to $60 million of stock (capped at 10% of the shares sold). The structure has been viewed as helping absorb incremental supply while allowing the company to opportunistically buy shares. (stocktitan.net)

With the divestiture completed, investors are increasingly focused on BrightSpring’s outlook for 2026 and the trajectory of its remaining businesses. In its latest results update, the company provided full-year 2026 guidance and highlighted strategic actions across its footprint, including integration of acquired home health and hospice branches tied to the Amedisys and LHC transactions. (ir.brightspringhealth.com)

Near-term, traders will be watching for follow-through in volume, additional updates on capital allocation after the divestiture, and any changes in sell-side positioning following the company’s 2026 growth framing. Investors will also look for incremental disclosure on operational execution in home health, hospice, and specialty/infusion pharmacy as the company cycles its post-transaction baseline.